Diabetes mellitus represents a growing concern, both for public economy and global health.
In fact, it can lead to insidious macrovascular and microvascular complications, impacting …

The ultimate purpose of diabetes care is achieving the outcomes that patients regard as
important throughout the life course. Despite advances in pharmaceuticals, nutraceuticals …

Abstract Aims To explore: 1) General Practitioners'(GPs') perspectives regarding initiating
SGLT2 inhibitors and the resources that inform their pharmacotherapy choices; and 2) The …

Theoretically, a new diagnosis of type 2 diabetes mellitus (T2DM) requires a dramatic
change in an individual's way of life. Weight loss and physical activity can lead to remission …

Introduction: Although therapeutic inertia is a known driver of suboptimal type 2 diabetes
control, little is known about how to combat this phenomenon. We analyzed randomized trial …

Objectives Therapeutic inertia in type 2 diabetes (T2DM) is the failure to receive timely
treatment intensification as indicated according to T2DM treatment guidelines. Multifactorial …

Introduction Psychological barriers to insulin therapy are associated with the delay of
clinically indicated treatment intensification for people with type 2 diabetes (T2D), yet few …

Objectives Although multiple causes of therapeutic inertia in type 2 diabetes mellitus (T2DM)
have been identified, few studies have addressed the behavioural aspects of treatment …

背景高血压是严重危害人群健康的常见慢性病, 基层医生是高血压管理的主力军,
而医源性治疗惰性在很大程度上影响了基层高血压控制的达标情况. 目的调查基层医生在高血压 …

Type 2 diabetes mellitus is a progressive disease requiring regular monitoring and
therapeutic changes. It is important that healthcare professionals embrace both ends of the …